| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.44 | 0.02 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.33 | 0.02 |